III Brazilian Thoracic Association Guidelines on tuberculosis
- PMID: 19918635
- DOI: 10.1590/s1806-37132009001000011
III Brazilian Thoracic Association Guidelines on tuberculosis
Abstract
New scientific articles about tuberculosis (TB) are published daily worldwide. However, it is difficult for health care workers, overloaded with work, to stay abreast of the latest research findings and to discern which information can and should be used in their daily practice on assisting TB patients. The purpose of the III Brazilian Thoracic Association (BTA) Guidelines on TB is to critically review the most recent national and international scientific information on TB, presenting an updated text with the most current and useful tools against TB to health care workers in our country. The III BTA Guidelines on TB have been developed by the BTA Committee on TB and the TB Work Group, based on the text of the II BTA Guidelines on TB (2004). We reviewed the following databases: LILACS (SciELO) and PubMed (Medline). The level of evidence of the cited articles was determined, and 24 recommendations on TB have been evaluated, discussed by all of the members of the BTA Committee on TB and of the TB Work Group, and highlighted. The first version of the present Guidelines was posted on the BTA website and was available for public consultation for three weeks. Comments and critiques were evaluated. The level of scientific evidence of each reference was evaluated before its acceptance for use in the final text.
Similar articles
-
[Tuberculosis in Asia].Kekkaku. 2002 Oct;77(10):693-7. Kekkaku. 2002. PMID: 12440145 Japanese.
-
Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America.MMWR Recomm Rep. 2005 Nov 4;54(RR-12):1-81. MMWR Recomm Rep. 2005. PMID: 16267499
-
Essentials of tuberculosis control for the practising physician. Tuberculosis Committee, Canadian Thoracic Society.CMAJ. 1994 May 15;150(10):1561-71. CMAJ. 1994. PMID: 8174026 Free PMC article.
-
Pediatric tuberculosis: new guidelines and recommendations.Curr Opin Pediatr. 2012 Jun;24(3):319-28. doi: 10.1097/MOP.0b013e32835357c3. Curr Opin Pediatr. 2012. PMID: 22568943 Review.
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
Cited by
-
Access and adherence to isoniazid preventive therapy and occurrence of active TB in a cohort of people living with HIV: a retrospective cohort study in Sao Paulo, Brazil.Rev Inst Med Trop Sao Paulo. 2020 Feb 7;62:e8. doi: 10.1590/S1678-9946202062008. eCollection 2020. Rev Inst Med Trop Sao Paulo. 2020. PMID: 32049259 Free PMC article.
-
Adequacy of recommendations for adverse event management in national and international treatment guidelines for rifampicin-susceptible tuberculosis: a systematic review.EClinicalMedicine. 2025 Mar 18;82:103148. doi: 10.1016/j.eclinm.2025.103148. eCollection 2025 Apr. EClinicalMedicine. 2025. PMID: 40166655 Free PMC article. Review.
-
Evaluation of QuantiFERON-TB Gold for the Diagnosis of Mycobacterium tuberculosis Infection in HTLV-1-Infected Patients.Viruses. 2024 Nov 30;16(12):1873. doi: 10.3390/v16121873. Viruses. 2024. PMID: 39772183 Free PMC article.
-
In vitro and in vivo activities of ruthenium(II) phosphine/diimine/picolinate complexes (SCAR) against Mycobacterium tuberculosis.PLoS One. 2013 May 28;8(5):e64242. doi: 10.1371/journal.pone.0064242. Print 2013. PLoS One. 2013. PMID: 23724039 Free PMC article.
-
Clinical and epidemiological profiles of individuals with drug-resistant tuberculosis.Mem Inst Oswaldo Cruz. 2015 Apr;110(2):235-48. doi: 10.1590/0074-02760140316. Epub 2015 Mar 31. Mem Inst Oswaldo Cruz. 2015. PMID: 25946248 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical